Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 08:44 am Sale |
2024-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX |
Deep Track Capital, LP | 3,460,756 4.650% |
-602,920 (-14.84%) |
Filing History |
| 2025-01-31 09:55 am Purchase |
2024-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX |
The Vanguard Group | 7,158,871 9.620% |
1,122,329 (+18.59%) |
Filing History |
| 2024-10-25 9:46 pm Purchase |
2024-10-10 | 13G | SpringWorks Therapeutics, Inc. SWTX |
Boxer Capital Management LLC | 3,421,541 4.600% |
3,421,541 (New Position) |
Filing History |
| 2024-02-14 6:41 pm Sale |
2023-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX |
EcoR1 Capital LLC | 0 0.000% |
-3,460,208 (Position Closed) |
Filing History |
| 2024-02-14 08:56 am Purchase |
2023-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX |
Deep Track Capital, LP | 4,063,676 5.530% |
809,544 (+24.88%) |
Filing History |
| 2024-02-13 5:14 pm Purchase |
2023-12-29 | 13G | SpringWorks Therapeutics, Inc. SWTX |
The Vanguard Group | 6,036,542 8.380% |
1,714,187 (+39.66%) |
Filing History |
| 2024-02-09 09:49 am Purchase |
2024-02-08 | 13G | SpringWorks Therapeutics, Inc. SWTX |
FMR CORP | 10,809,235 15.000% |
1,449,145 (+15.48%) |
Filing History |
| 2024-01-26 11:49 am Purchase |
2023-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX |
BLACKROCK INC BLK |
5,382,184 7.500% |
2,057,446 (+61.88%) |
Filing History |
| 2024-01-23 10:22 am Sale |
2023-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX |
STATE STREET CORP STT |
2,619,650 3.640% |
-1,136,039 (-30.25%) |
Filing History |
| 2023-12-06 4:43 pm Sale |
2023-12-04 | 13D | SpringWorks Therapeutics, Inc. SWTX |
ORBIMED ADVISORS LLC | 3,567,159 4.900% |
-611,429 (-14.63%) |
Filing History |
| 2023-05-17 4:46 pm Sale |
2023-05-15 | 13D | SpringWorks Therapeutics, Inc. SWTX |
ORBIMED ADVISORS LLC | 4,178,588 6.700% |
-806,412 (-16.18%) |
Filing History |
| 2023-04-14 4:35 pm Purchase |
2023-04-04 | 13G | SpringWorks Therapeutics, Inc. SWTX |
Deep Track Capital, LP | 3,254,132 5.210% |
3,254,132 (New Position) |
Filing History |
| 2023-03-20 5:01 pm Sale |
2023-03-16 | 13D | SpringWorks Therapeutics, Inc. SWTX |
BC SW LP | 3,081,307 4.900% |
-1,750,000 (-36.22%) |
Filing History |
| 2023-02-14 2:31 pm Sale |
2022-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX |
PERCEPTIVE ADVISORS LLC | 2,617,691 4.200% |
-2,232,221 (-46.03%) |
Filing History |
| 2023-02-10 12:08 pm Purchase |
2022-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX |
STATE STREET CORP STT |
3,755,689 6.020% |
3,755,689 (New Position) |
Filing History |
| 2023-02-09 12:31 pm Purchase |
2023-02-09 | 13G | SpringWorks Therapeutics, Inc. SWTX |
FMR CORP | 9,360,090 15.004% |
3,313,881 (+54.81%) |
Filing History |
| 2023-02-09 11:32 am Purchase |
2022-12-30 | 13G | SpringWorks Therapeutics, Inc. SWTX |
The Vanguard Group | 4,322,355 6.930% |
1,460,043 (+51.01%) |
Filing History |
| 2023-02-07 12:59 pm Purchase |
2022-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX |
BLACKROCK INC BLK |
3,324,738 5.300% |
3,324,738 (New Position) |
Filing History |
| 2023-01-05 4:40 pm Sale |
2023-01-03 | 13D | SpringWorks Therapeutics, Inc. SWTX |
ORBIMED ADVISORS LLC | 4,985,000 8.000% |
-614,842 (-10.98%) |
Filing History |
| 2022-09-19 4:30 pm Purchase |
2022-09-09 | 13G | SpringWorks Therapeutics, Inc. SWTX |
Boxer Capital LLC | 3,421,541 5.700% |
3,421,541 (New Position) |
Filing History |